Fifty years of drug discovery from fungi
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abraham E (1990) Selective reminiscences of beta-lactam antibiotics: early research on penicillin and cephalosporins. Bioessays 12:601–606
Abraham EP, Chain E, Fletcher CM, Gardner AD, Heatley NG, Jennings MA, Florey HW (1941) Further observations on penicillin. Lancet 238:177–189
Ago H, Oda M, Takahashi M, Tsuge H, Ochi S, Katunuma N, Miyano M, Sakurai J (2006) Structural basis of the sphingomyelin phosphodiesterase activity in neutral sphingomyelinase from Bacillus cereus. J Biol Chem 281:16157–16167
Ahmed F, Williams RA, Smith KE (1996) Microbial transformations of steroids—X. Cytochromes P-450 11 alpha-hydroxylase and C17-C20 lyase and a 1-ene dehydrogenase transform steroids in Nectria haematococca. J Steroid Biochem Mol Biol 58:337–349
Alanis AJ (2005) Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 36:697–705
Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, Patchett A, Monaghan R, Currie S, Stapley E, Albers-Schonberg G, Hensens O, Hirshfield J, Hoogsteen K, Liesch J, Springer J (1980) Mevinolin: a high potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 77:3957–3961
Aly AH, Debbab A, Kjer J, Proksch P (2010) Fungal endophytes from higher plants: a prolific source of phytochemicals and other bioactive natural products. Fungal Divers 41:1–16
Ammermann E, Lorenz G, Schelberger K, Wenderoth B, Sauter H, Rentzea C (1992) Brighton Crop Prot Conf: pests and diseases. British Crop Protection Council, Farnham, p 403
Ammermann E, Lorenz G, Schelberger K, Mueller B, Kirstgen R, Sauter H (2000) BAS 500 F—the new broad-spectrum strobilurin fungicide. In: Proc Brighton Crop Protect Conf: Pests and Diseases. British Crop Protection Council, Farnham, UK, pp 541–548
Anderson JD (1980) Fusidic acid: new opportunities with an old antibiotic. Can Med Assoc J 122:765–769
Anke T (1995) The antifungal strobilurins and their possible ecological role. Can J Bot 73:S940–S945
Anke T, Thines E (2007) Fungal metabolites as lead structures for agriculture. In: Robson GD, Van West P, Gadd GM (eds) Exploitation of fungi. Cambridge University Press, Cambridge, pp 45–58
Anke T, Oberwinkler F, Steglich W, Schramm G (1977) The strobilurins—new antifungal antibiotics from the basidiomycete Strobilurus tenacellus. J Antibiot 30:806–810
Anke T, Hecht HJ, Schramm G, Steglich W (1979) Antibiotics from basidiornycetes. IX. Oudemansin, an antifungal antibiotic from Oudemansiella mucida (Schrader ex Fr.) Hoehnel (Agaricales). J Antibiot 32:1112–1117
Anke T, Besl H, Mocek U, Steglich W (1983) Antibiotics from basidiomycetes. XVIII. Strobilurin C and oudemansin B, two new antifungal metabolites from Xerula species (Agaricales). J Antibiot 36:661–666
Appel J, Felsenstein FG (2000) Entwicklung der Strobilurinresistenz des Weizenmehltaus in Europa in den Jahren 1998 bis 2000. Mitt Biol Bundesanst 376:97
Barry AL, Jones RN (1987) In vitro activity of ciprofloxacin against gram-positive cocci. Am J Med 82:27–32
Bartett DW, Clough JM, Godfrey CRA, Godwin JR, Hall AA, Heaney SP, Maund SJ (2001) Understanding the strobilurin fungicides. Pestic Outlook 12:143–148
Beautement K, Clough JM (1987) Stereocontrolled syntheses of strobilurin A and its (9E)-isomer. Tetrahedron Lett 28:475–478
Becker WF, von Jagow G, Anke T, Steglich W (1981) Oudemansin, strobilurin A, strobilurin B and myxothiazol: new inhibitors of the bc1 segment of the respiratory chain with an E-beta-methoxyacrylate system as common structural element. FEBS Lett 132:329–333
Bergstralh DT, Ting JP (2006) Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. Cancer Treat Rev 32:166–179
Black WA, McNellis DA (1971) Comparative in-vitro sensitivity of Nocardia species to fusidic acid and sulphonamides. J Med Microbiol 4:293–295
Blunt JW, Copp BR, Munro MHG, Northcote PT, Prinsep MR (2011) Marine natural products. Nat Prod Rep. doi: 10.1039/C005001F
Borel JF, Kis ZL (1991) The discovery and development of cyclosporine. Transplant Proc 23:1867–1874
Borges KB, Borges WDS, Pupo MT, Bonato PS (2007) Endophytic fungi as models for the stereoselective biotransformation of thioridazine. Appl Microbiol Biotechnol 77:669–674
Bortolini O, Medici A, Poli S (1997) Biotransformations of the steroid nucleus of bile acids. Steroids 62:564–577
Buckland B, Gbewonyo K, Hallada T, Kaplan L, Masurekar P (1989) Production of lovastatin, an inhibitor of cholesterol accumulation in humans. In: Demain AL, Somkuti GA, Hunter-Cevera JC, Rossmore HW (eds) Novel microbial product for medicine and agriculture. Elsevier, Amsterdam, pp 161–169
Chadwick AJ, Jackson B (1969) Intraocular penetration of the antibiotic fucidin. Br J Ophthalmol 53:26–29
Chen SCA, Slavin MA, Sorrell TC (2011) Echinocandin antifungal drugs in fungal infections: a comparison. Drugs 71:11–41
Clough JM (2000) The strobilurin fungicides—from mushroom to molecule to market. In: Wrigley SK, Hayes MA, Thomas R, Chrystal EJT, Nicholson N (eds) Biodiversity: new leads for the pharmaceutical and agrochemical industries. The Royal Society of Chemistry, Cambridge, pp 277–282
Conder GA, Johnson SS, Nowakowski DS, Blake TE, Dutton FE, Nelson SJ, Thomas EM, Davis JP, Thompson DP (1995) Anthelmintic profile of the cyclodepsipeptide PF1022A in in vitro and in vivo models. J Antibiot 48:820–823
Crabtree GR (1999) Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 96:611–614
Czarny M, Schnitzer JE (2004) Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium. Am J Physiol Heart Circ Physiol 287:H1344–H1352
Dayan FE, Cantrell CL, Duke SO (2009) Natural products in crop protection. Bioorg Med Chem 17:4022–4034
Demain AL (2000) Small bugs, big business: the economic power of the microbe. Biotechnol Adv 18:499–514
Demain AL, Elander RP (1999) The β-lactam antibiotics: past, present, and future. Antonie Leeuwenhoek 75:5–19
Denning DW (1997) Echinocandins and pneumocandins—a new antifungal class with a novel mode of action. J Antimicrob Chemother 40:611–614
Dewick PM (2006) Medicinal natural products. A biosynthetic approach. Wiley, Baffins Lane
Dornetshuber R, Kamyar MR, Rawnduzi P, Baburin I, Kouri K, Pilz E, Hornbogen T, Zocher R, Berger W, Lemmens-Gruber R (2009) Effects of the anthelmintic drug PF1022A on mammalian tissue and cells. Biochem Pharmacol 77:1437–1444
Dowson CG, Hutchison A, Brannigan JA, George RC, Hansman D, Liñares J, Tomasz A, Smith JM, Spratt BG (1989) Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci USA 86:8842–8846
Elander RP (2003) Industrial production of β-lactam antibiotics. Appl Microbiol Biotechnol 61:385–392
El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, Shimotohno K, Kawahata T, Otake T (1998) Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry 49:1651–1657
Elrod J, Wong R, Mishra S, Vagnozzi RJ, Sakthievel B, Goonasekera SA, Karch J, Gabel S, Farber J, Force T, Brown JH, Murphy E, Molkentin JD (2010) Cyclophilin D controls mitochondrial pore-dependent Ca2+ exchange, metabolic flexibility, and propensity for heart failure in mice. J Clin Invest 120:3680–3687
Endo A, Kuroda M, Tsujita Y (1976) ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot 29:1346–1348
Faber M, Rosdahl VT (1990) Susceptibility to fusidic acid among Danish Staphylococcus aureus strains and fusidic acid consumption. J Antimicrob Chemother 25:7–14
Falagas ME, Grammatikos AP, Michalopoulos A (2008) Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther 6:593–600
Fernandes P, Cruz A, Angelova B, Pinheiro HM, Cabral JMS (2003) Microbial conversion of steroid compounds: recent developments. Enzyme Microb Technol 32:688–705
Fleming A (1980) Classics in infectious diseases: on the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae by Alexander Fleming, Reprinted from the British Journal of Experimental Pathology 10: 226–236, 1929. Rev Infect Dis 2:129–139
Fredenhagen A, Kuhn A, Peter HH, Cuomo V, Giuliano U (1990) Strobilurins F, G and H, three new antifungal metabolites from Bolinea lutea. I. Fermentation, isolation and biological activity. J Antibiot 43:655–660
Ganong WF (2005) Review of medical physiology, 22nd edn. Lange Medical Books, pp 530
Godtfredsen W, Roholt K, Tybring L (1962a) Fucidin. A new orally active antibiotic. Lancet 279:928–931
Godtfredsen WO, Jahnsen S, Lorck H, Roholt K, Tybring L (1962b) Fusidic acid; a new antibiotic. Nature 193:987
Godtfredsen WO, Von Daehne W, Tybring L, Vangedal S (1966) Fusidic acid derivatives. I. Relationship between structure and antibacterial activity. J Med Chem 9:15–22
Godwin JR, Anthony VM, Clough JM, Godfrey CRA (1992) Brighton Crop Prot Conf: pests and diseases. British Crop Protection Council, Farnham, p 435
Godwin JR, Bartlett DW, Clough JM, Godfrey CRA, Harrison EG, Maund S (2000) Picoxystrobin: a new strobilurin fungicide for use on cereals. In: Proc Brighton Crop Protect Conf: Pests and Diseases. British Crop Protection Council, Farnham, UK, pp 533–540
Griffiths HJ (1978) A handbook of veterinary parasitology: domestic animals of North America. University of Minnesota Press, Minneapolis, pp 46–47
Grove JF, MacMillan J, Mulholland TPC, Rogers MAT (1952) Griseofulvin. Part IV. Structure. J Chem Soc 3977–3987
Guenthner SH, Wenzel RP (1984) In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillinresistant Staphylococcus aureus. Antimicrob Agents Chemother 26:268–269
Gunatilaka AAL (2006) Natural products from plant-associated microorganisms: distribution, structural diversity, bioactivity, and implication of their occurence. J Nat Prod 69:509–526
Hagel I, Giusti T (2010) Ascaris lumbricoides: an overview of therapeutic targets. Infect Disord Drug Targets 10:349–367
Hannun YA, Obeid LM (2002) The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277:25847–25850
Harder A, Schmitt-Wrede HP, Krücken J, Marinovski P, Wunderlich F, Willson J, Amliwala K, Holden-Dye L, Walker R (2003) Cyclooctadepsipeptides—an anthelmintically active class of compounds exhibiting a novel mode of action. Int J Antimicrob Agents 22:318–331
Hayase Y, Kataoka T, Masuko M, Niikawa M, Ichinari M, Takenaka H, Takahashi T, Hayashi Y, Takeda R (1995) Phenoxyphenyl alkoxyiminoacetamides. New broad-spectrum fungicides. In: Baker DR, Fenyes JG, Basarab GS (eds) Synthesis and chemistry of agrochemicals IV. ACS Symposium Series 584. American Chemical Society, Washington DC, pp 343–353
Hensens OD, Ondeyka JG, Dombrowski AW, Ostlind DA, Zink DL (1999) Isolation and structure of nodulisporic acid A1 and A2, novel insecticides from a Nodulisporium sp. Tetrahedron Lett 40:5455–5458
Ho YS, Duh JS, Jeng JH, Wang YJ, Liang YC, Lin CH, Tseng CJ, Yu CF, Chen RJ, Lin JK (2001) Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. Int J Cancer 91:393–401
Holliday J, Cleaver M (2008) Medicinal value of the caterpillar fungi species of the genus Cordyceps (Fr.) Link (Ascomycetes): a review. Int J Med Mushr 10:219–234
Holten KB, Onusko EM (2000) Appropriate prescribing of oral beta-lactam antibiotics. Am Fam Physician 62:611–620
Hosokawa T, Inui S, Murahashi SI (1983) Ganoderic acid T and Z: cytotoxic triterpenes from Ganoderma lucidum. Tetrahedron Lett 24:1081–1084
Houchins J, Hind G (1983) Flash spectroscopic characterization of photosynthetic electron transport in isolated heterocysts. Arch Biochem Biophys 224:272–282
Hoye TR, Tennakoon MA (2000) Synthesis (and alternative proof of configuration) of the scyphostatin C(1′)-C(20′) trienoyl fragment. Org Lett 2:1481–1483
IMS Health (2005) Annual Report on prescription drug trends. www.imshealth.com
IMS Health (2008) Annual Report on prescription drug trends. www.imshealth.com
Irrgang S, Schlosser D, Fritsche W (1997) Involvement of cytochrome P-450 in the 15alpha-hydroxylation of 13-ethyl-gon-4-ene-3,17-dione by Penicillium raistrickii. J Steroid Biochem Mol Biol 60:339–346
Ishii H, Fraaije BA, Sugiyama T, Noguchi K, Nishimura K, Takeda T, Amano T, Hollomon DW (2001) Occurrence and molecular characterization of strobilurin resistance in cucumber powdery mildew and downy mildew. Phytopathology 91:1166–1171
Izuhara T, Katoh T (2001) Studies toward the total synthesis of scyphostatin: first entry to the highly functionalized cyclohexenone segment. Org Lett 3:1653–1656
Jeschke P, Harder A, Etzel W, Gau W, Thielking G, Bonse G, Iinuma K (2001) Synthesis and anthelmintic activity of thioamide analogues of cyclic octadepsipeptides such as PF1022A. Pest Manag Sci 57:1000–1006
Kanski JJ (1974) Treatment of late endophthalmitis associated with filtering blebs. Arch Ophthalmol 91:339–343
Keller-Juslen C, Kuhn M, Loosli H-R, Pechter TJ, von Weber HP, Wartburg A (1976) Structure des cyclopeptideantibiotikum SL 7810 (Echinocandin B). Tetrahedron Lett 17:4147–4150
Khan MA, Tania M, Zhang DZ, Chen HC (2010) Cordyceps mushroom: a potent anticancer nutraceutical. Open Nutraceuticals J 3:179–183
Kharwar RN, Mishra A, Gond SK, Stierle A, Stierle D (2011) Anticancer compounds derived from fungal endophytes: their importance and future challenges. Nat Prod Rep. doi: 10.1039/C1NP00008J
Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J Am Med Assoc 298:1763–1771
Koester DH (1937) United States Patent 2, 236, 574
Kolesnick R, Golde DW (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325–328
Kubota T, Asaka Y, Miura I, Mori H (1982) Structures of ganoderic acid A and B, two new lanostane type bitter triterpenes from Ganoderma lucidum (Fr.) Karst. Helv Chim Acta 65:611–619
Larsen TO, Smedsgaard J, Nielsen KF, Hansen ME, Frisvad JC (2005) Phenotypic taxonomy and metabolite profiling in microbial drug discovery. Nat Prod Rep 22:672–695
Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Br Med J 326:1423–1429
Lee BH, Dutton FE, Thompson DP, Thomas EM (2002) Generation of a small library of cyclodepsipeptide PF1022A analogues using a cyclization-cleavage method with oxime resin. Bioorg Med Chem Lett 12:353–356
Leigh DA (1974) Clinical importance of infections due to Bacteroides fragilis and role of antibiotic therapy. Br Med J 3:225–228
Lesemann SS, Schimpke S, Dunemann F, Deising HB (2006) Mitochondrial heteroplasmy for the cytochrome b gene controls the level of strobilurin resistance in the apple powdery mildew fungus Podosphaera leucotricha (Ell. & Ev.) E.S. Salmon. J Plant Dis Protect 113:259–266
Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370:1829–1839
Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841–1845
Lindequist U, Rausch R, Füssel A, Hanssen HP (2010) Higher fungi in traditional and modern medicine. Med Monatsschr Pharm 33:40–48
MacGowan AP, Greig MA, Andrews JM, Reeves DS, Wise R (1989) Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers. J Antimicrob Chemother 23:409–415
Mahato SB, Banerjee S (1985) Steroid transformation by microorganisms II. Phytochemistry 24:1403–1421
Mahato SB, Mukherjee A (1984) Steroid transformations by microorganisms. Phytochemistry 23:2131–2154
Maksay G, Laube B, Betz H (2001) Subunit-specific modulation of glycine receptors by neurosteroids. Neuropharmacology 41:369–376
Malaviya A, Gomes J (2008) Androstenedione production by biotransformation of phytosterols. Bioresour Technol 99:6725–6737
Mamoh L (1937) United States Patent 2, 186, 9006
Manosroia J, Saowakhonb S, Manosroia A (2007) A novel one-step biotransformation of cortexolone-21-acetate to hydrocortisone acetate using Cunninghamella blakesleeana ATCC 8688a. Enzyme Microb Technol 41:322–325
Margot P, Huggenberger F, Amrein J, Weiss B (1998) CGA 279202: a new broad-spectrum strobilurin fungicide. In: Proc Brighton Crop Protect Conf: Pests and Diseases. British Crop Protection Council, Farnham, UK, pp 375–382
Markowski M, Ungeheuer M, Bitran D, Locurto C (2001) Memory enhancing effect of DHEAS in aged mice on a win-shaft water escape task. Physiol Behav 72:521–525
Mehlhom H (1988) Parasitology in focus, facts and trends. Springer, New York
Meinke PT, Colletti SL, Fisher MH, Wyvratt MJ, Shih TL, Ayer MB, Li C, Lim J, Ok D, Salva S, Warmke LM, Zakson M, Michael BF, deMontigny P, Ostlind DA, Fink D, Drag M, Schmatz DM, Shoop WL (2009) Discovery of the development candidate N-tert-butyl nodulisporamide: a safe and efficacious once monthly oral agent for the control of fleas and ticks on companion animals. J Med Chem 52:3505–3515
Mellon SH, Griffin LD (2002) Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab 13:35–43
Miles RS, Moyes A (1978) Comparison of susceptibility of Neisseria meningitidis to sodium sulphadiazine and sodium fusidate in vitro. J Clin Pathol 31:355–358
Moisan H, Pruneau M, Malouin F (2010) Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae. J Antimicrob Chemother 65:713–716
Morris MI, Villmann M (2006a) Echinocandins in the management of invasive fungal infections, part 1. Am J Health Syst Pharm 63:1693–1703
Morris MI, Villmann M (2006b) Echinocandins in the management of invasive fungal infections, Part 2. Am J Health Syst Pharm 63:1813–1820
Mostafa ME, Zohri AA (2000) Progesterone side-chain degradation by some species of Aspergillus flavus group. Folia Microbiol 45:243–247
Mott JL, Zhang D, Freeman JC, Mikolajczak P, Chang SW, Zassenhaus HP (2004) Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A. Biochem Biophys Res Commun 319:1210–1215
Murray HC, Peterson DH (1952) United States Patent 2602769
Nara F, Tanaka M, Hosoya T, Suzuki-Konagai K, Ogita T (1999a) Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties. J Antibiot 52:525–530
Nara F, Tanaka M, Masuda-Inoue S, Yamasato Y, Doi-Yoshioka H, Suzuki-Konagai K, Kumakura S, Ogita T (1999b) Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima. J Antibiot 52:531–535
Negishi S, Cai-Huang Z, Hasumi K, Murakawa S, Endo A (1986) Productivity of molacolin K (mevilonin) in the genus Monascus. Hakko Kogaku Kaishi 64:509–512
Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461–477
Newton GGF, Abraham EP (1955) Cephalosporin C, a new antibiotic containing sulphur and D-α-aminoadipic acid. Nature 175:548
Nishitoba T, Sato H, Shirasu S, Sakamura S (1987) Novel triterpenoids from the mycelial mat at the previous stage of fruiting of G. lucidum. Agric Biol Chem 51:619–622
Nissen S, Nicholls S, Sipahi I, Libby P, Raichlen J, Ballantyne C, Davignon J, Erbel R, Fruchart J, Tardif J, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu E (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. J Am Med Assoc 295:1556–1565
Ondeyka JG, Helms GL, Hensens OD, Goetz MA, Zink DL, Tsipouras A, Shoop WL, Slayton L, Dombrowski AW, Polishook JD, Ostlind DA, Tsou NN, Ball RG, Singh SB (1997) Nodulisporic acid A, a novel and potent insecticide from a Nodulisporium sp. isolation, structure determination, and chemical transformations. J Am Chem Soc 119:8809–8816
Osbourn AE, Lanzotti V (2009) Plant-derived natural products: synthesis, function, and application. Springer, New York
Otaka T, Kaji A (1973) Evidence that fusidic acid inhibits the binding of aminoacyl-tRNA to the donor as well as the acceptor site of the ribosomes. Eur J Biochem 38:46–53
Panda D, Rathinasamy K, Santra MK, Wilson L (2005) Kinetic suppression of microtubule dynamic instability by griseofulvin: implications for its possible use in the treatment of cancer. PNAS 102:9878–9883
Paz Z, Komon-Zelazowska M, Druzhinina IS, Aveskamp MM, Shnaiderman A, Aluma Y, Carmeli S, Ilan M, Yarden O (2010) Diversity and potential antifungal properties of fungi associated with a Mediterranean sponge. Fungal Divers 42:17–26
Petrič S, Hakki T, Bernhardt R, Zigon D, Crešnar B (2010) Discovery of a steroid 11α-hydroxylase from Rhizopus oryzae and its biotechnological application. J Biotechnol 150:428–437
Pimentel MR, Molina G, Dionísio AP, Maróstica Junior MR, Pastore GM (2011) The use of endophytes to obtain bioactive compounds and their application in biotransformation process. Biotechnol Res Int, Article ID: 576286, doi: 10.4061/2011/576286
Pohold DJ, Saravolatz LD, Somerville MM (1987) In vitro susceptibility of gram-positive cocci to LY146032, teicoplanin, sodium fusidate, vancomycin, and rifampicin. J Antimicrob Chemother 20:197–202
Poucheretpet P, Fons F, Rapior S (2006) Biological and pharmacological activity of higher fungi: 20-year retrospective analysis. Cryptogamie Mycol 27:311–333
Pritchard DI (2005) Sourcing a chemical succession for cyclosporin from parasites and human pathogens. Drug Discov Today 10:688–691
Rateb ME, Ebel R (2011) Secondary metabolites of fungi from marine habitats. Nat Prod Rep 28:290–344
Ravn HO (1967) Fucidin og novobiocin som kombinationsbehandling ved akut osteomyelitis og ostitis. Ugeskr Laeger 129:15
Rebacz B, Larsen TO, Clausen MH, Rønnest MH, Löffler H, Ho AD, Krämer A (2007) Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen. Cancer Res 67:6342–6350
Richardson MD, Warnock DW (2003) Fungal infection: diagnosis and management, 3rd edn. Blackwell Publishing Ltd, Oxford, pp 70–72
Robel P, Baulieu E-E (1995) Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Ann NY Acad Sci 774:82–110
Runcie KA, Taylor RJK (2001) A short and efficient route to novel scyphostatin analogues. Org Lett 3:3237–3239
Rupprecht R, Holsboer F (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22:410–416
Saito S, Tanaka N, Fujimoto K, Kogen H (2000) Absolute configuration of scyphostatin. Org Lett 2:505–506
Sallam LAR, El-Refai AM, El-Minofi HA (2005) Physiological and biochemical improvement of the enzyme side-chain degradation of cholesterol by Fusarium solani. Process Biochem 40:203–206
Samanta TB, Ghosh DK (1987) Characterization of progesterone 11 alpha-hydroxylase of Aspergillus ochraceus TS: a cytochrome P-450 linked monooxygenase. J Steroid Biochem 28:327–332
Sasaki T, Takagi M, Yaguchi T, Miyadoh S, Okada T, Koyama M (1992) A new anthelmintic cyclodepsipeptide, PF1022A. J Antibiot 45:692–697
Sauter H, Steglich W, Anke T (1999) Strobilurins: evolution of new class of active substances. Angew Chem Int Ed 38:1328–1349
Scherkenbeck J, Harder A, Plant A, Dyker H (1998) PF1022A—a novel anthelmintic cyclooctadepsipeptide. Modification and exchange of the N-methyl leucine residues. Bioorg Med Chem Lett 8:1035–1040
Schoeller W (1937) United States Patent 2, 184, 167
Schwartz RE, Giacobbe RA, Boand JA, Monaghan RL (1989) L-671,329, a new antifungal agent. I. Fermentation and isolation. J Antibiot 42:163–167
Shaw LM (1989) Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring. Clin Chem 35:1299–1308
Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S (2008) Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 9:662–673
Shieh YH, Liu CF, Huang YK, Yang JY, Wu IL, Lin CH, Li SC (2001) Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice. Am J Clin Med 29:501–507
Shkumatov VM, Usova EV, Poljakov YS, Frolova NS, Radyuk VG, Mauersberger S, Chernogolov AA, Honeck H, Schunck WH (2002) Biotransformation of steroids by a recombinant yeast strain expressing bovine cytochrome P-45017α. Biochemistry 67:456–467
Shoop WL, Gregory LM, Zakson-Aiken M, Michael BF, Haines HW, Ondeyka JG, Meinke PT, Schmatz DM (2001) Systemic efficacy of nodulisporic acid against fleas on dogs. J Parasitol 87:419–423
Siev M, Weinberg R, Penman S (1969) The selective interruption of nucleolar RNA synthesis in HELA cells by cordycepin. J Cell Biol 41:510–520
Singh SB, Barrett JF (2006) Empirical antibacterial drug discovery—foundation in natural products. Biochem Pharmacol 71:1006–1015
Smith D, Ryan MJ (2009) Fungal sources for new drug discovery. AccessScience, ©McGraw-Hill Companies, http://www.accessscience.com
Sonomoto K, Hoq MMD, Tanaka A, Fukui S (1981) Growth of Curvularia lunata spores into mycelial form with various gels, and steroid 11β-hydroxy1ation by the entrapped mycelia. J Ferment Technol 59:465–469
Stirling J, Goodwin S (1977) Susceptibility Bacteroides fragilis to fusidic acid. J Antimicrob Chemother 3:522–523
Strobel G, Daisy B (2003) Bioprospecting for microbial endophytes and their natural products. Microbiol Mol Biol Rev 67:491–502
Sweetman SC (2009) Cardiovascular drugs. Martindale: the complete drug reference, 36th edn. Pharmaceutical Press, London, pp 1155–1434
Taburet AM, Guibert J, Kitzis MD, Sorensen H, Acar JF, Singlas E (1990) Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation. J Antimicrob Chemother 25:23–31
Tanaka N, Kinoshita T, Masukawa H (1968) Mechanism of protein synthesis inhibition by fusidic acid and related antibiotics. Biochem Biophys Res Commun 15:278–283
Tanaka M, Nara F, Suzuki-Konagai K, Hosoya T, Ogita T (1997) Structural elucidation of scyphostatin, an inhibitor of membrane-bound neutral sphingomyelinase. J Am Chem Soc 119:7871–7872
Tang YJ, Zhong JJ (2004) Modeling the kinetics of cell growth and ganoderic acid production in liquid static cultures of the medicinal mushroom Ganoderma lucidum. Biochem Eng J 21:259–264
Tang W, Gu T, Zhong JJ (2006) Separation of targeted ganoderic acids from Ganoderma lucidum by reversed phase liquid chromatography with ultraviolet and mass spectrometry detections. Biochem Eng J 32:205–210
Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, Ebrahim S (2011) Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev:CD004816
Tidwell TT (2008) Hugo (Ugo) Schiff, Schiff bases, and a century of β-lactam synthesis. Angew Chem Int Edit 47:1016–1020
Verza M, Arakawa NS, Lopes NP, Kato MJ, Pupo MT, Said S, Carvalho I (2009) Biotransformation of a tetrahydrofuran lignan by the endophytic fungus Phomopsis sp. J Braz Chem Soc 20:195–200
Viola F, Caputo O, Balliano G, Delprino L, Cattel L (1983) Side chain degradation and microbial reduction of different steroids by Aspergillus auroefulgens. J Steroid Biochem 19:1451–1458
von Benz F, Knusel F, Nuesch J, Treichler H, Voser W, Nyfeler R, Keller-Schierlein W (1974) Echinocandin B, ein neuartiges polipeptide-antibiotikum aus Aspergillus nidulans var. echinatus: Isolierung und Bausteine. Helv Chim Acta 57:2459–2477
von Daehne W, Godtfredsen WO, Rasmussen PR (1979) Structureactivity relationships in fusidic acid-type antibiotics. Adv Appl Microbiol 25:95–146
Von Jagow G, Gribble GW, Trumpower BL (1986) Mucidin and strobilurin A are identical and inhibit electron transfer in the cytochrome bc 1 complex of the mitochondrial respiratory chain at the same site as myxothiazol. Biochemistry 25:775–780
von Samson-Himmelstjerna G, Harder A, Sangster NC, Coles GC (2005) Efficacy of two cyclooctadepsipeptides, PF1022A and emodepside, against anthelmintic-resistant nematodes in sheep and cattle. Parasitology 130:343–347
Waldmeier PC, Zimmermann K, Qian T, Tintelnot-Blomley M, Lemasters JJ (2003) Cyclophilin D as a drug target. Curr Med Chem 10:1485–1506
Wasser SP (2002) Medicinal mushrooms as a source of antitumor and immunomodulatory polysaccharides. Appl Microbiol Biotechnol 60:258–274
Wasser SP, Weis AL (1999) Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modem perspective. Crit Rev Immunol 19:65–96
Waxman DJ, Strominger JL (1983) Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics. Annu Rev Biochem 52:825–869
Weber W, Anke T, Steffan B, Steglich W (1990) Antibiotics from basidiomycetes. XXXII. Strobilurin E: a new cytostatic and antifungal (E)-beta-methoxyacrylate antibiotic from Crepidotus fulvotomentosus Peck. J Antibiot 43:207–212
Welte T, Pletz MW (2010) Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options. Int J Antimicrob Agents 36:391–400
Whelan RS, Kaplinskiy V, Kitsis RN (2010) Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 72:19–44
Williams DH, Stone MJ, Hauck PR, Rahman SK (1989) Why are secondary metabolites (natural products) biosynthesized? J Nat Prod 52:1189–1208
Williamson J, Russell F, Doig WM, Paterson RW (1970) Estimation of sodium fusidate levels in human serum, aqueous humour, and vitreous body. Br J Ophthalmol 54:126–130
Wise R, Pippard M, Mitchard M (1977) The disposition of sodium fusidate in man. Br J Clin Pharmacol 4:615–619
Xu J, Ebada SS, Proksch P (2010) Pestalotiopsis a highly creative genus: chemistry and bioactivity of secondary metabolites. Fungal Divers 44:15–31
Yamashita M, Katsumata M, Iwashima M, Kimura M, Shimizu C, Kamata T, Shin T, Seki N, Suzuki S, Taniguchi M, Nakayama T (2000) T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex. J Exp Med 191:1869–1879
Yaskowiak ES, March PE (1995) Small clusters of divergent amino acids surrounding the effector domain mediate the varied phenotypes of EF-G and LepA expression. Mol Microbiol 15:943–953
Yoon SY, Eo SK, Kim YS, Lee CK, Han SS (1994) Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm Res 17:438–442
Zakharychev VV, Kovalenko LV (1998) Natural compounds of the strobilurin series and their synthetic analogues as cell respiration inhibitors. Russ Chem Rev 67:535–544
Zeelen FJ (1990) Medicinal chemistry of steroids. Elsevier, Amsterdam